Press Releases ViroGates A/S

Equities

VIRO

DK0061030574

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 15/07/2024 pm IST			5-day change	1st Jan Change
6.45 ^DKK	-0.77%		-3.01%	+7.14%

02/05	ViroGates A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
15/04	Virogates A/S Announces the Outcome of Its Q-Submission Filing for Sobi®? Turbi Latex with the Us Food and Drug Administration	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ViroGates A/S : Interim Report, Q1 2024	02/05	PU
ViroGates announces its Interim Report for Q1, 2024: Quarterly revenue up 14% compared to Q1, 2023	02/05	AQ
Resolutions from the Annual General Meeting of ViroGates A/S	26/04	AQ
ViroGates announces the outcome of its Q-Submission filing for suPARnostic® TurbiLatex with the US FDA and the overall timeline for filing a submission of a 510k/“De Novo” application with the FDA	15/04	AQ
ViroGates gives notice to convene the Annual General Meeting on 25 April 2024	10/04	AQ
ViroGates announces its Annual Report 2023: Revenue was affected by the loss of COVID-19 customers and a difficult transition into general triage	21/03	AQ
Subscription of shares by majority shareholder in relation to the recently completed rights emission in ViroGates A/S	21/12	AQ
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19	21/12	AQ
ViroGates publishes its financial calendar for 2024	21/12	AQ
ViroGates announces financial guidance for 2024	21/12	AQ
ViroGates' capital raise of DKK 13.9 million and issue of 3,097,047 new shares have been registered	19/12	AQ
ViroGates announces the outcome of its rights issue	15/12	AQ
ViroGates A/S : Most interesting suPAR studies of 2023	08/12	PU
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19	07/12	AQ
ViroGates A/S : Clinical role of suPAR in the prognosis of patients in the emergency setting and its influence on risk stratification	06/12	PU
The subscription period in ViroGates’ rights issue begins today	30/11	AQ
Resolutions from the Extraordinary General Meeting of ViroGates A/S	24/11	AQ
ViroGates A/S : Social isolation in mid-adulthood is associated with elevated suPAR	23/11	PU
ViroGates gives notice to convene an Extraordinary General Meeting on 24 November 2023	09/11	AQ
ViroGates announces an offering of new shares with pre-emptive rights for existing shareholders	09/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ViroGates A/S

Equities

VIRO

DK0061030574

Press Releases

Filters